SUBMIT YOUR RESEARCH
Saudi Journal of Medicine (SJM)
Volume-10 | Issue-07 | 313-316
Case Report
Challenges in Follicular Radioiodine-Refractory Differentiated Thyroid Cancer (RAIR-DTC), a Focus in the TKI Agents
Dr. Mamadou Togo, Dr. Mariam Hamaichat, Dr Mohamed MALAD, Pr. Ahmed Anas Guerboub
Published : July 5, 2025
DOI : https://doi.org/10.36348/sjm.2025.v10i07.003
Abstract
Papillary carcinoma of the thyroid is a follicular type cancer, constituting the dominant histological type of all malignant neoplasms affecting the thyroid gland. His prognosis is generally favorable. The situations where this cancer becomes refractory to the action of radio-metabolic therapy are a real challenge for any clinician. The surgical resumption whenever possible, the use of chemotherapy with tyrosine kinase inhibiting agents, and external radiation therapy are the pillars of management in this type of cancer. We expose through three observations this issue and we discuss the approach toward this clinical situation.
Scholars Middle East Publishers
Browse Journals
Payments
Publication Ethics
SUBMIT ARTICLE
Browse Journals
Payments
Publication Ethics
SUBMIT ARTICLE
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
© Copyright Scholars Middle East Publisher. All Rights Reserved.